Belite Bio, Inc reported earnings of -$ 0.60 per BLTE share on Nov 12, 2026, falling short of analysts' expectations by
| Report Date | Nov 12, 2026 |
|---|---|
| Forecasted EPS | -$ 0.79 |
| Earnings Per Share (Surprise) | -$ 0.60 (+$ 0.1863) |
| Last Year's EPS | -$ 0.50 |
| EPS YoY Change |
Out of the last 27 earnings reporting periods, Belite Bio, Inc beat analysts’ expectations 8 times and fell short of expectations 9 time(s). Belite Bio, Inc reported earnings per share of -$ 0.60 in the last report surpassing an estimated EPS of -$ 0.79 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 0.79 | -$ 0.60 | -$ 0.65 | |
| Aug 12, 2026 | -$ 0.73 | -$ 0.70 | -$ 0.50 | |
| May 20, 2026 | -$ 0.60 | -$ 0.34 | -$ 0.45 | |
| Mar 2, 2026 | -$ 0.56 | -$ 0.38 | -$ 0.32 | |
| Nov 10, 2025 | -$ 0.53 | -$ 0.65 | -$ 0.28 | |
| Aug 11, 2025 | -$ 0.47 | -$ 0.50 | -$ 0.31 | |
| May 13, 2025 | -$ 0.36 | -$ 0.45 | -$ 0.27 | |
| Mar 17, 2025 | -$ 0.30 | -$ 0.32 | -$ 0.25 | |
| Nov 12, 2024 | -$ 0.30 | -$ 0.28 | -$ 0.40 | |
| Aug 9, 2024 | -$ 0.28 | -$ 0.31 | -$ 0.26 | |
| May 13, 2024 | -$ 0.34 | -$ 0.27 | -$ 0.33 | |
| Mar 11, 2024 | -$ 0.36 | -$ 0.25 | -$ 1.04 | |
| Nov 13, 2023 | -$ 0.31 | -$ 0.40 | -$ 0.10 | |
| Aug 8, 2023 | -$ 0.24 | -$ 0.26 | -$ 0.12 | |
| May 10, 2023 | -$ 0.20 | -$ 0.33 | -$ 0.26 | |
| Mar 31, 2023 | -$ 0.22 | -$ 1.04 | -$ 0.05 | |
| Sep 30, 2022 | - | -$ 0.10 | -$ 0.26 | |
| Aug 10, 2022 | -$ 0.23 | -$ 0.12 | -$ 0.25 | |
| Apr 29, 2022 | - | -$ 0.26 | -$ 0.25 | |
| Mar 31, 2022 | - | -$ 0.05 | -$ 0.21 |
Belite Bio, Inc’s stock was trading at $ 155.94 on Nov 11, 2026 a day before the last earnings report was released.Following the release of the earnings report, BLTE’s price increased to $ 164.36 on Nov 13, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 0.60 | $ 155.94 | $ 164.36 | |
| Aug 12, 2026 | -$ 0.70 | $ 177.58 | $ 166.28 | |
| May 20, 2026 | -$ 0.34 | $ 139.70 | $ 144.25 | |
| Mar 2, 2026 | -$ 0.38 | $ 190.30 | $ 167.88 | |
| Nov 10, 2025 | -$ 0.65 | $ 113.19 | $ 105.76 | |
| Aug 11, 2025 | -$ 0.50 | $ 69.88 | $ 72.73 | |
| May 13, 2025 | -$ 0.45 | $ 61.99 | $ 61.60 | |
| Mar 17, 2025 | -$ 0.32 | $ 67.44 | $ 68.38 | |
| Nov 12, 2024 | -$ 0.28 | $ 78.64 | $ 82.23 | |
| Aug 9, 2024 | -$ 0.31 | $ 49.24 | $ 48.55 | |
| May 13, 2024 | -$ 0.27 | $ 42.05 | $ 42.00 | |
| Mar 11, 2024 | -$ 0.25 | $ 46.05 | $ 39.04 | |
| Nov 13, 2023 | -$ 0.40 | $ 39.34 | $ 37.88 | |
| Aug 8, 2023 | -$ 0.26 | $ 22.54 | $ 23.06 | |
| May 10, 2023 | -$ 0.33 | $ 25.20 | $ 26.81 | |
| Mar 31, 2023 | -$ 1.04 | $ 29.50 | $ 28.51 | |
| Sep 30, 2022 | -$ 0.10 | $ 32.93 | $ 29.10 | |
| Aug 10, 2022 | -$ 0.12 | $ 28.22 | $ 30.77 | |
| Apr 29, 2022 | -$ 0.26 | $ 8.87 |
Belite Bio, Inc released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Belite Bio, Inc beat analysts’ expectations during the last earnings period by
